-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

-UNDP India New Delhi: "Social media is changing the way we live and relate to each other" said noted filmmaker Shekhar Kapur. The challenge in his view, was "how to ensure those ideas are positive and for the good?" Mr. Kapur was speaking at the Social Good Summit 2014, ‘Technology for Social Good' organized by the United Nations Development Programme in India. Talking of his vision for the world in 2030,...

-The Times of India A new self regulatory code of conduct for doctors and hospitals, in the process of being formulated, could hold investors and members on the boards of medical establishments responsible for unethical practices in the establishment such as giving cuts to doctors and diagnostic facilities or taking bribes from pharmaceutical companies. The Indian Medical Association (IMA) and the Association of Hospital Providers of India (AHPI) have constituted a joint...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...

-The Indian Express For a government that won office on the plank of fighting corruption and promising ‘‘achhe din'' to citizens disgruntled by poor service delivery, one would have thought putting in place an effective anti-corruption and grievance redressal framework would be a top priority. However, after 100 days of being in power, the Modi sarkar's report card on transparency and accountability disappoints. It is well established that openness in government functioning...